Daniel E Carvajal
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
- Cancer Cells and Metastasis 1
- HER2/EGFR in Cancer Research 1
-
- Breast Cancer Treatment Studies 1
- Co-authors
- David L. Rimm (3 shared papers)Kurt Alex Schalper (4 shared papers)Vamsidhar Velcheti (2 shared papers)Roy S. Herbst (1 shared paper)Valsamo Anagnostou (1 shared paper)Scott N. Gettinger (1 shared paper)Lieping Chen (1 shared paper)Mario Sznol (1 shared paper)
- Journals
- Laboratory Investigation (2 papers)Surgical Endoscopy (1 paper)Clinical Cancer Research (1 paper)Revista médica de Chile (1 paper)
- Partner nations
- United StatesChileColombia
In The Last Decade
Daniel E Carvajal
5 papers receiving 1.1k citations
Daniel E Carvajal's Hit Papers
Peers
Comparison fields: 5 of 42
- Oncology 829
- Immunology 295
- Pulmonary and Respiratory Medicine 238
- Cancer Research 86
- Genetics 31
Countries citing papers authored by Daniel E Carvajal
This map shows the geographic impact of Daniel E Carvajal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E Carvajal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E Carvajal more than expected).
Fields of papers citing papers by Daniel E Carvajal
This network shows the impact of papers produced by Daniel E Carvajal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E Carvajal. The network helps show where Daniel E Carvajal may publish in the future.
Co-authors
The 20 scholars most cited alongside Daniel E Carvajal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Programmed death ligand-1 expression in non-small cell lung cancer Hit paper breakdown → | 2013 | 687 |
| 2 | 2014 | 395 | |
| 3 | 2018 | 14 | |
| 4 | 2016 | 9 | |
| 5 | 2013 | 2 |
About Daniel E Carvajal
Daniel E Carvajal is a scholar working on Oncology, Cancer Research, Immunology, Surgery and Molecular Biology, having authored 5 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Breast Cancer Treatment Studies (1 paper), Gene expression and cancer classification (1 paper), Advanced Biosensing Techniques and Applications (1 paper), Cancer Cells and Metastasis (1 paper), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper), Immunotherapy and Immune Responses (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Oncology (829 citations), Immunology (295 citations), Pulmonary and Respiratory Medicine (238 citations), Cancer Research (86 citations) and Genetics (31 citations). Daniel E Carvajal has collaborated with scholars based in United States, Chile and Colombia. Frequent co-authors include David L. Rimm, Kurt Alex Schalper, Vamsidhar Velcheti, Roy S. Herbst, Valsamo Anagnostou, Scott N. Gettinger, Lieping Chen, Mario Sznol, Konstantinos Nikolaos Syrigos and Lajos Pusztai. Their work appears in journals such as Laboratory Investigation, Surgical Endoscopy, Clinical Cancer Research and Revista médica de Chile.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.